Crispr Therapeutics shares owned by Point72 Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.7M | 51k | 52.44 |
| 2025-03-31 | $3.4M | 100k | 34.03 |
| 2019-09-30 | $265k | 6.5k | 41.05 |
| 2019-06-30 | $332k | 7.1k | 47.05 |
| 2019-03-31 | $162k | 4.5k | 35.80 |